SCHEMBL2859239

SCHEMBL2859239

Cc1c(O)ccc(C(=O)c2ccccc2)c1O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.56
HSD17B10 Q99714 4/20 0.56
MAPK1 P28482 2/20 0.56
ALOX15 P16050 2/20 0.56
KDM4E B2RXH2 2/20 0.56
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
USP2 O75604 1/20 0.53
GAA P10253 1/20 0.53
KEAP1 Q14145 1/20 0.53
NFE2L2 Q16236 1/20 0.53
LMNA P02545 3/20 0.51
HTT P42858 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
ALDH1A1 P00352 2/20 0.50
HPGD P15428 2/20 0.50
CYP1A2 P05177 1/20 0.50
PGR P06401 1/20 0.50
CYP2D6 P10635 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30331291 1.00 MAPT (0.56) MAPTHSD17B10MAPK1ALOX15KDM4E
SCHEMBL3879139 0.87 GAA (0.55) MAPTHSD17B10MAPK1ALOX15KDM4E
SCHEMBL9172083 0.85 MAPT (0.56) MAPTHSD17B10MAPK1ALOX15KDM4E
SCHEMBL27508628 0.85 GAA (0.53) MAPTHSD17B10MAPK1ALOX15KDM4E
SCHEMBL29215682 0.85 ALDH1A1 (0.54) MAPTHSD17B10MAPK1ALOX15KDM4E
SCHEMBL11211367 0.85 MAPT (0.56) MAPTHSD17B10MAPK1ALOX15KDM4E
SCHEMBL1758260 0.84 KMT2A (0.51) MAPTHSD17B10ALOX15KDM4EMEN1
SCHEMBL30996458 0.83 POLB (0.55) MAPTHSD17B10ALOX15KDM4EMEN1
SCHEMBL29215536 0.83 POLB (0.55) MAPTHSD17B10ALOX15KDM4EMEN1
SCHEMBL29366285 0.82 HDAC1 (0.66) MAPTHSD17B10MAPK1ALOX15KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250179000-A1 METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATORS (PAMS) AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute 2025-06-05 US disclosed
EP-4452918-A1 METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATORS (PAMS) AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute (US) 2024-10-30 EP disclosed
WO-2023122276-A1 METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATORS (PAMS) AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute (US) 2023-06-29 WO disclosed
US-9394555-B2 Compositions comprising a polypeptide having cellulolytic enhancing activity and a dioxy compound and uses thereof NOVOZYMES, INC. (US) 2016-07-19 US disclosed
US-20130157317-A1 Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Dioxy Compound And Uses Thereof NOVOZYMES, INC. (US) 2013-06-20 US disclosed
US-7713449-B2 Polymer electrolytic material, polymer electrolytic part, membrane electrode assembly, and polymer electrolyte fuel cell TORAY INDUSTRIES, INC. (JP) 2010-05-11 US disclosed
CN-100364160-C Polymer electrolyte material, polymer electrolyte part, membrane electrode composite and polymer electrolyte type fuel cell TORAY INDUSTRIES (JP) 2008-01-23 CN disclosed
US-20060180796-A1 Polymer electrolyte material, polymer electrolyte part, membrane electrode composite and polymer electrolyte type fuel cell TORAY INDUSTRIES, INC. (JP) 2006-08-17 US disclosed
EP-1619735-A1 POLYMER ELECTROLYTE MATERIAL, POLYMER ELECTROLYTE PART, MEMBRANE ELECTRODE COMPOSITE AND POLYMER ELECTROLYTE TYPE FUEL CELL TORAY INDUSTRIES, INC. (JP) 2006-01-25 EP disclosed
US-20050288346-A1 Acetophenone potentiators of metabotropic glutamate receptors MERCK & CO., INC. 2005-12-29 US disclosed
EP-0846673-A1 High molecular weight dibenzoylresorcinol UV absorbers GENERAL ELECTRIC COMPANY (US) 1998-06-10 EP disclosed
US-5763674-A High molecular weight dibenzoylresorcinol UV absorbers GENERAL ELECTRIC COMPANY (US) 1998-06-09 US disclosed
EP-0240723-B1 UV-LIGHT STABILIZER COMPOSITION COMPRISING CYCLIC ALIPHATIC EPOXY, UV SCREENER, AND POLYALKYLDIPIPERIDINE (HALS) COMPOUNDS GENERAL ELECTRIC COMPANY (US) 1993-06-23 EP disclosed
US-5026751-A For a polyphenylene ether, 2-hydroxybenzophenone GENERAL ELECTRIC COMPANY (US) 1991-06-25 US disclosed
US-4843116-A SHAPED PLASTICS GENERAL ELECTRIC COMPANY (US) 1989-06-27 US disclosed
EP-0240723-A2 UV-light stabilizer composition comprising cyclic aliphatic epoxy, UV screener, and polyalkyldipiperidine (HALS) compounds GENERAL ELECTRIC COMPANY (US) 1987-10-14 EP disclosed
US-4349607-A UV Stabilizers, coating compositions and composite structures obtained therefrom GENERAL ELECTRIC COMPANY (US) 1982-09-14 US disclosed
US-4349607-A UV Stabilizers, coating compositions and composite structures obtained therefrom GENERAL ELECTRIC COMPANY (US) 1982-09-14 US disclosed
US-4288631-A 3-ALKYLHYDROXYBENZOPHENONES GENERAL ELECTRIC COMPANY (US) 1981-09-08 US disclosed
US-4288631-A 3-ALKYLHYDROXYBENZOPHENONES GENERAL ELECTRIC COMPANY (US) 1981-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250179000-A1 METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATORS (PAMS) AND USES THEREOF GRM3, GRM2, GRM1 MAPT 1240/4885HSD17B10 3733/4885MAPK1 1549/4885
US-20050288346-A1 Acetophenone potentiators of metabotropic glutamate receptors GRM2, GRM1, GRIK2 MAPT 1622/4885HSD17B10 372/4885MAPK1 1716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.